Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia

PURPOSE OF REVIEW: Minimally invasive surgical therapies (MISTs) have emerged as an alternative to the standard surgical treatment for patients with BPH. The purpose of this review is to summarize the primary literature evaluating clinical efficacy, safety, and durability of these procedures. RECENT FINDINGS: UroLift and Rezūm have been established to offer significant improvement in urinary symptoms, Qmax, while preserving ejaculatory function. Emerging techniques such as Optilume and implantable prostatic devices show promising short-term outcomes in improvement of urinary symptoms with preservation of sexual function, but longer-term durability remains to be established. There is a lack of high-quality studies comparing MISTs head-to-head or to surgical standards. MISTs offer symptom improvement with preservation of sexual function in the ambulatory setting. Individual procedures offer distinct advantages and treatment selection should be individualized through shared decision-making incorporating both patient preferences and anatomic considerations.

Authors

Institutions

Publication Details

Journal
Current Urology Reports
Published
2026-11-19
DOI
https://doi.org/10.1007/s11934-026-01369-6
Primary Topic
Urinary Bladder and Prostate Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia

Jennifer E. Lloyd-Harris, Shirley L. Wang, Christopher D. Herrera
2 links
Current Urology Reports
Urinary Bladder and Prostate Research
article

Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia

Jennifer E. Lloyd-Harris, Shirley L. Wang, Christopher D. Herrera
article en

Abstract

PURPOSE OF REVIEW: Minimally invasive surgical therapies (MISTs) have emerged as an alternative to the standard surgical treatment for patients with BPH. The purpose of this review is to summarize the primary literature evaluating clinical efficacy, safety, and durability of these procedures. RECENT FINDINGS: UroLift and Rezūm have been established to offer significant improvement in urinary symptoms, Qmax, while preserving ejaculatory function. Emerging techniques such as Optilume and implantable prostatic devices show promising short-term outcomes in improvement of urinary symptoms with preservation of sexual function, but longer-term durability remains to be established. There is a lack of high-quality studies comparing MISTs head-to-head or to surgical standards. MISTs offer symptom improvement with preservation of sexual function in the ambulatory setting. Individual procedures offer distinct advantages and treatment selection should be individualized through shared decision-making incorporating both patient preferences and anatomic considerations.

Current Urology ReportsVol. 27(1)
University of Pennsylvania Health System (US), University of Pennsylvania (US)
Good health and well-being
Urinary Bladder and Prostate Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon